We study the mechanisms of acquired immunity to malaria, SARS-CoV-2 and filariasis with a focus on humoral immunity. This work involves B cell molecular immunology and development human monoclonal antibodies as therapies. We also develop novel tools for control and elimination of lymphatic filariasis and onchocerciasis.
- immunologic response to prenatal parasite exposure
- vaccine development